Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Scientists in Amsterdam Just Destroyed Breast Cancer Tumors in 11 Days Without Chemo

Wednesday, November 16, 2016 21:03
% of readers think this story is Fact. Add your two cents.

(Before It's News)

by Organic and Healthy

Scientists in Europe may have found a breakthrough for the most common cancer in women.

Around 1 in 8 American women will develop breast cancer in their lifetime; the clinical trial may have found a way to rid us of it once and for all in the future.

Breast Cancer Breakthrough

B4INREMOTE-aHR0cHM6Ly8zLmJwLmJsb2dzcG90LmNvbS8tcnZQVW5LdlJSTDgvV0N6T01LMkN0TUkvQUFBQUFBQUFIaTAvNGpYTXdrbUVFSHd1N0pNWXJfZXJpUThLRDFNelFHc2ZBQ0xjQi9zNjQwL0Rlc3Ryb3llZCUyQkJyZWFzdCUyQkNhbmNlciUyQlR1bW9ycy5KUEc=

Research presented by Professor Nigel Bundred at the European Breast Cancer Conference in Amsterdam revealed that they had tested the effectiveness of a pair of drugs known as Herceptin (a.k.a trastuzumab) and Lapatinib.
The two drugs are commonly used in breast cancer treatment already, but this is the first time they had been combined together and used before surgery and chemotherapy. What they found was they were able to eliminate some types of breast cancer in just 11 days.

Funded by Cancer Research UK, they aimed to use these drugs to combat a protein called HER2 (human epidermal growth factor receptor 2) which affects the growth and division of cancer cells. It’s also more likely to return than other cancer types.

What also makes this treatment so appealing is the fact that it eliminates the need for chemotherapy and surgery. The temporary side effects like hair loss, vomiting and fatigue are also avoided, making treatment less impactful on the body. Chemo is not entirely effective, nor is it the right choice for a lot of patients, so any alternatives are welcomed.

Study Results

257 women with HER2 positive breast cancer were selected for the study, with half being put on the drug combo and the other half were the control group. What they found was that of those on the drug, 11% had no cancer cells remaining within two weeks and 17% of cases featured dramatically shrunken tumors.

Compared to the control group who were only given Herceptin, they were found to have 0% with no trace of cancer cells and only 3% showed a drop in tumor size. Clearly, the two drugs combined have a major effect on breast cancer cells as opposed to being used on their own.

The problem currently, however, is that Herceptin’s licensing makes it only available for use alongside chemotherapy and not alone. The results of this study may help to change that though.

Although there’s still a lot of work to be done, hopefully, this is a major step in the fight against one of the world’s deadliest diseases. With medical advancements improving every year, it’s entirely possible this could happen sooner than we think!

Let’s block ads! (Why?)

Every Day is Earth Day

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.